← FDA Drug Approvals (Drugs@FDA)
IRBESARTAN
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: IPCA LABS LTD · Approved 2024-05-22
Drug application
- FDA Application #
ANDA211056- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- IRBESARTAN
- Generic name
- Irbesartan
- Active ingredients
- IRBESARTAN
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- IPCA LABS LTD
- First approval
- 2024-05-22
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown